NYSE: GL

Globe Life (GL) Stock Analysis & Forecast

Nov 13 close

$160.74+0.63 (+0.4%)

Gekko Brief

AI summaryNov 9 close

This week's attention on Globe Life centers on its quarterly dividend declaration of $0.33 per share, payable 1 February 2027 to shareholders of record as of 8 January 2027, repeated across several reports as a routine action rather than an operating update. Coverage also references the Q3 2026 earnings call, where modest operating income growth was driven by higher premiums, while Medicare Supplement processing issues and high-severity claims at Evri pressured health margins and led to a reduction in per-share earnings guidance. Separately, Globe Life was named alongside Aflac, Unum, Trupanion and Employers in a broader industry outlook piece, and MarketBeat cited a "Moderate Buy" consensus from eleven analysts.

Shares closed at $161.83, up 3% on the day, sitting between the 50-day average of $166.64 and the 200-day average of $160.34, with the one-month return at -1.4% and the three-month return at -10.6%, against a one-year gain of 22.8%. The GekkoIndex reads 62.6, placing the stock in the Accumulation zone, down from a five-day change of -2.2. Price sits 7.1% below Gekko Fair Value of $174.19.

The next earnings date falls on 3 February 2027, 85 days out, placing it outside a typical 20-trading-day holding window. No insider, Congress or unusual options activity appears in their respective windows. Seasonally, the next 20 trading days have averaged a 1.3% return over 5 years, rising in 3 of those years. Analyst consensus carries a $185.18 price target among 6 firms, with 5 rating it buy and 1 hold.

Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.

Globe Life price vs fair value

$173.47$160.74Nov ’25May ’26Nov ’26
Close $160.74200-day averageGekko Fair Value $173.47

Globe Life quick facts

Market cap
$12.13B
P/E ratio
10.7
Forward P/E
9.5
EPS, TTM
$14.94
Revenue, TTM
$6.27B
Profit margin
18.9%
Dividend yield
0.78%
Beta
0.46
Volume
360,618 avg 633,486
1-year return
+20.0%
Typical daily move
±2.1%
Typical 20-day move
±3.5%
50-day average
$165.66
200-day average
$160.80
Next earnings
Feb 3
Shares outstanding
75.44M
52-week range
$129.21$191.55

Globe Life swing-trade checklist

Globe Life scores 4 supportive, 1 mixed and 0 headwinds across the 5 checklist items with data.

Six things swing traders check before a 20-day hold, read from the latest data.

4 supportive1 mixed0 headwinds

  • Trendmixed

    Averages disagree

    Close $160.74 sits between the 50-day ($165.66) and 200-day ($160.80) averages, or the averages disagree.

    See the chart
  • GekkoIndexsupportive

    60.8, Accumulation

    Reading 60.8 is in the Accumulation zone.

    See the GekkoIndex
  • Fair valuesupportive

    7.3% below

    Price is 7.3% below Gekko Fair Value (more than 5% below).

    See fair value
  • Smart moneyno data

    No data

    No insider, Congress or unusual options activity in the window.

    See smart money
  • Earnings risksupportive

    Reports in 80 days

    Next report Feb 3, 2027, 80 days away — outside a typical 20-trading-day hold.

    See earnings
  • Seasonalitysupportive

    +1.8% on average

    From this point in the calendar, the next 20 trading days averaged +1.8% over 5 years, rising in 3 of them.

    See seasonality

A description of current data, not a recommendation. How this page works

Globe Life stock chart and price history

Globe Life closed at $160.74 on Nov 13, 2026, +20.0% over the past year, inside a 52-week range of $129.21 to $191.55.

Close50-day average200-day averageVolume
Globe Life share price, past year, with 50-day and 200-day moving averages and volume$140$180DecJan 2026FebMarAprMayJunJulAugSepOctNov160.74

Use the left and right arrow keys to read daily values.

Performance Breakdown

1 month
−4.1%
3 months
−10.4%
6 months
+3.7%
1 year
+20.0%
The full GL chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open GL in Gekko

Follow Globe Life through every session

Put GL on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.

Track GL in GekkoFree for 7 days. No credit card required.

About Globe Life

Globe Life provides life insurance, supplemental health coverage, and annuity products, with a focus on serving households in the lower-middle to middle-income range across the United States. Its life insurance lineup includes whole life and term life policies, while its health-related offerings cover Medicare supplements, critical illness protection, and accident coverage. The annuity business includes both single-premium and flexible-premium deferred options.

The company runs its business through four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. This structure separates its core insurance products from the investment activities that support them, giving a clearer view of how each part of the business contributes to results.

Globe Life traces its founding to 1979 and operates out of McKinney, Texas. It previously carried the name Torchmark Corporation before adopting its current name in August 2019. Its shares are listed on the NYSE under the ticker GL.

Listed
NYSE
Sector
Finance
Industry
Multi-line insurance
Website
home.globelifeinsurance.com

Globe Life GekkoIndex: the smart money zone

Globe Life’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 60.8, in the Accumulation zone, down 5.5 points over five sessions.

010060.8Accumulation

Down 5.5 points over five sessions.

Reading for Nov 13, 2026

What followed past readings in each zone

ZoneReadings5 days10 days20 days50 days
Buying29−3.2%−1.8%−3.8%−0.6%
Accumulation (current zone)182+1.2%+1.1%+1.1%+5.9%
Neutral418+0.4%+0.8%+1.9%+3.9%
Distribution69−0.1%+0.5%+1.3%−1.0%
Selling4Too few readings yet

Average GL share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.0% over 20 days. Past behaviour doesn’t guarantee future results.

Accumulation zone: Institutional interest building. About the five zones →

See every daily GekkoIndex reading plotted over the GL price, zone by zone.Track GL in Gekko

Is Globe Life stock overvalued? Gekko Fair Value

Globe Life trades 7.3% below Gekko Fair Value of $173.47, so the shares are undervalued on Gekko’s estimate.

Gekko’s own estimate of what Globe Life shares are worth, recalculated every trading day.

$173.47

Gekko Fair Value, Nov 14, 2026

7.3% Undervalued

At the end of Aug 2026 the price was 8.4% below the estimate.

Gekko Fair ValueShare price, month end
$173$161Aug 2026SepOctNov 2026

How Gekko Fair Value works →

Gekko Fair Value on every chart, with the gap to price updating daily.Open GL in Gekko

Globe Life insider and Congress trading

No open-market insider purchases were filed for Globe Life, and no Congress trades were disclosed, in the last 90 days.

Plus buybacks, unusual options and fund positions, each dated to when it became public.

Insider buying last 90 days

No open-market insider purchases were filed for GL in the last 90 days.

From Form 4 filings, dated to when each was filed.

Every GL insider filing, plotted on the chart in Gekko.Open GL in Gekko

Congress trades last 90 days

No trades in GL were disclosed by members of Congress in the last 90 days.

From congressional disclosures, which report amounts as ranges.

Congress disclosures for GL, plotted on the chart in Gekko.Open GL in Gekko

Buybacks

Globe Life has been buying back its own shares.

Bought back, quarter ended Sep 30, 2026
$218.0M
As a share of market cap
1.80%
Trailing four quarters
$925.4M

From company filings.

Hedge funds and billionaires quarter ended Sep 30

1of the funds Gekko tracks holds GL.

1added0opened0trimmed0sold out
Which funds are on each side, name by name.Unlock in Gekko

Globe Life earnings: next date and track record

Globe Life reports on Feb 3, 2027 (80 days away), and beat the EPS estimate in 3 of its last 8 reports.

3 of 8reports beat the EPS estimate
±3.3%average move across the report
3 of 8reports followed by a gain

Share-price move across each report

−2.0%Feb ’25−5.0%Apr ’25+7.1%Jul ’25−0.2%Oct ’25+2.3%Feb ’26+2.0%Apr ’26−7.2%Jul ’26−0.8%Oct ’26

Last earnings call, Oct 21, 2026 AI summary

What they said
Globe Life reported Q3 net operating income of $4.84 per share, up 1% year-over-year, while net income declined 2% to $4.62 per share. Total premium revenue grew 7%, with health premiums surging 16% to $447 million. Book value per share rose 23% to $85.35. Results were impacted by a CMS process change affecting United American and high severity claims at Evri. The company received reciprocal jurisdiction regulatory approval to enhance financial flexibility.
Guidance
Full-year total premium revenue growth expected at ~6.5%, with life premiums growing 2.5%-2.75% and health premiums ~15%. Life underwriting margin targeted at 44%-45% for 2026; health underwriting margin at 22%-24%. Administrative expenses expected to hold at ~7.3% of premium.
ReportedEPSSurpriseRevenueSurpriseMove
Oct 21, 2026$4.84
est $4.90
−1.2%$1.60B
est $1.56B
+2.2%−0.8%
Jul 22, 2026$3.61
est $3.67
−1.6%$1.60B
est $1.59B
+0.6%−7.2%
Apr 22, 2026$3.43
est $3.48
−1.4%$1.56B
est $1.56B
−0.3%+2.0%
Feb 4, 2026$3.39
est $3.44
−1.5%$1.52B
est $1.53B
−0.8%+2.3%
Oct 22, 2025$4.81
est $4.60
+4.6%$1.51B
est $1.52B
−0.4%−0.2%
Jul 23, 2025$3.27
est $3.25
+0.6%$1.48B
est $1.51B
−1.6%+7.1%
Apr 30, 2025$3.07
est $3.23
−5.0%$1.48B
est $1.49B
−0.5%−5.0%
Feb 5, 2025$3.14
est $3.12
+0.6%$1.47B
est $1.48B
−0.7%−2.0%

“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.

Globe Life stock forecast and analyst price targets

Analysts’ average 12-month price target for Globe Life is $185.18, +15.2% from the last close, from 6 firms rating the stock in the last 90 days.

$185.18consensus 12-month target, +15.2% from the last close
Low $165High $215
Buy5
Hold1
Sell0

Each firm’s latest rating in the last 90 days: 6 firms.

Latest analyst actions

DateFirmRatingTargetvs price
Oct 26Wells FargoBuy, reiterated$180+12.0%
Oct 26KBWBuy, maintained$182+13.2%
Oct 23TD CowenBuy, maintained$215+33.8%
Oct 23Piper SandlerHold, downgraded$165+2.7%
Oct 23Morgan StanleyBuy, reiterated$197+22.6%
+1.1%average 20-day move after past Accumulation readings
+1.8%average move over the next 20 trading days in the last 5 years
±2.1%typical daily move, from the 14-day average range

Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.

Globe Life seasonality: the next 20 trading days

Over the next 20 trading days from Nov 14, Globe Life averaged +1.8% across the last 5 years, rising in 3 of them.

Next 20 trading days, by year

−2.9%2021+5.6%2022+4.7%2023−3.3%2024+6.7%2025

Average move and hit rate

WindowAverageYears higher
Next 5 trading days+0.5%3 of 5
Next 10 trading days+0.3%4 of 5
Next 15 trading days+1.4%3 of 5
Next 20 trading days+1.8%3 of 5
Next 30 trading days+3.6%4 of 5

For scale, GL’s typical 20-trading-day move in either direction is about 3.5%.

Globe Life market cap and key statistics

Globe Life’s market cap is $12.13B, with a P/E ratio of 10.7 and revenue of $6.27B over the last twelve months.

Valuation

Market cap
$12.13B
P/E ratio
10.7
Forward P/E
9.5
EPS, TTM
$14.94
Gekko Fair Value
$173.47

Trading

Volume
360,618
Avg volume, 20 days
633,486
52-week high
$191.55
52-week low
$129.21
Shares outstanding
75.44M

Financials

Revenue, TTM
$6.27B
Profit margin
18.9%
Return on equity
19.3%
Quarterly earnings growth, YoY
−2.3%

Risk and income

Beta
0.46
Typical daily move
±2.1%
Typical 20-day move
±3.5%
Dividend yield
0.78%

Globe Life stock news this week

Coverage of Globe Life this week reads positive: 5 positive, 5 neutral and 0 negative headlines.

News sentiment positive

Globe Life peers

Globe Life’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.

StockTodayGekkoIndex zonevs Fair Value
PGRProgressive−0.9%Neutral4.8% above
MFCManulife Financial−0.6%Neutral9.7% above
ALLAllstate−0.7%Neutral3.5% above
METMetLife−0.2%Neutral0.8% below
AFLAFLAC+0.1%Neutral7.6% above
AIGAIG−0.4%Neutral0.8% above

A peer links to its own page where one exists.

In the Buying zone today

Reporting earnings this week

Popular on Gekko

More stocks in Multi-line insurance

Globe Life stock FAQ

What is Globe Life’s market cap?

Globe Life’s market cap is $12.13B at the Nov 13, 2026 close of $160.74, with 75.44M shares outstanding. The shares trade on a P/E ratio of 10.7.

What is the Globe Life stock forecast?

The consensus analyst 12-month price target for Globe Life is $185.18, +15.2% from the last close. Of the 6 firms that rated the stock in the last 90 days, 5 rate it a buy, 1 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.

Is Globe Life stock overvalued or undervalued?

On Gekko’s estimate Globe Life is undervalued: the Nov 13, 2026 close of $160.74 is 7.3% below Gekko Fair Value of $173.47. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.

When does Globe Life report earnings next?

Globe Life is expected to report on Feb 3, 2027 (80 days away). Analysts expect earnings of $3.60 per share on revenue of $1.62B. Globe Life beat the earnings estimate in 3 of its last 8 reports, moving 3.3% on average across the report.

What is Globe Life’s 52-week high and low?

Globe Life’s 52-week high is $191.55 and its 52-week low is $129.21; it closed at $160.74 on Nov 13, 2026, +20.0% over the past year.

Is Globe Life stock a buy right now?

Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 4 of the 5 items with data read as supportive (gekkoindex, fair value, earnings risk and seasonality), 1 as mixed (trend). The checklist is a description of current data, not a recommendation.

How this page works

During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →

See Globe Life the way Gekko members do

Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.

Join 1,475 other traders using Gekko

Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.